New mass photometer enables rapid, autonomous, and label-free mass characterisation of biomolecules at the single-molecule level Oxford, UK – Refeyn, the mass photometry pioneer, has announced the launch of its new TwoMP Auto mass photometer, a unique instrument for the automatic loading and analysis of biomolecular samples for protein characterisation at the single-molecule level. Launched at SLAS in Boston, […]

BOSTON — At the annual Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, BioAuxilium Research Inc., a biotech tool company focused on facilitating access to fully validated assay kits to the biomedical research community, today announced the expansion of its no-wash THUNDER™ time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio by introducing new cell signaling […]

VectorBuilder Inc. and Pall Corporation are establishing the VectorBuilder-Pall Center for Gene Therapy to optimize adherent cell-based GMP manufacturing of viral vectors for cell therapy, gene therapy and vaccine applications. Situated within VectorBuilder’s GMP facilities, the center will feature Pall’s small-scale iCELLis™ Nano and clinical-scale iCELLis 500+ bioreactors. This integration of the companies’ technical knowledge […]

IPSWICH, Mass. — Today, New England Biolabs (NEB®) announced the release of its first lyophilized product manufactured by Fluorogenics: the LyoPrime Luna Probe One-Step RT-qPCR Mix with UDG. This lyophilized master mix exhibits the same versatile features and strong performance of the previously released liquid 4X mix and enables sensitive, linear real-time detection of target RNA […]

Shionogi & Co., Ltd. (Head office: Chuo-ku, Osaka; President & CEO: Isao Teshirogi; hereafter “Shionogi”) and Shimadzu Corporation (Head office: Nakagyo-ku, Kyoto; President & CEO: Teruhisa Ueda; hereafter “Shimadzu”) announced the establishment of AdvanSentinel Inc. (Head office: Chuo-ku, Osaka; President & CEO: Masatoshi Koga; hereafter “AdvanSentinel”), a joint venture for the purpose of conducting public […]

SANTA CLARA, Calif., and LIVERMORE, Calif. — Applied Cells, a leading provider of cell preparation and isolation solutions for tumor biology research, today announced a joint marketing agreement with S2 Genomics to further the field of tumor biology. The joint program leverages S2 Genomics’ Proprietary Singulator™ 100 System for dissociation of solid tissue into cell and nuclei suspensions […]

Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe C2i to integrate Twist’s library preparation kits into minimal residual disease workflow NEW YORK & SOUTH SAN FRANCISCO, Calif. — C2i Genomics, a cancer intelligence company, and Twist Bioscience […]

Thermo Fisher Scientific expands Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers CARLSBAD, Calif. — Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis,is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease, […]

Element Biosciences will offer both short-read and long-read sequencing on a common platform. Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced that the company has closed its acquisition of Loop Genomics, a long-read solutions company that enables short-read sequencers to obtain long-range information. Loop Genomics’ Chief Executive Officer and Founder, Tuval […]